Endothelin in the female vasculature: a role in aging?

Area of Science:

• Cardiovascular Biology
• Endocrinology
• Gerontology

Background:

• Cardiovascular diseases (CVDs) are a leading global cause of death.
• Aging increases CVD incidence, with women facing heightened risk post-menopause.
• Female sex hormones offer vasoprotection, which diminishes after menopause.

Purpose of the Study:

• To review hormone-dependent pathways linking endothelin-1 (ET-1) to vascular aging in postmenopausal women.
• To elucidate the role of the ET-1 system in age-related vascular dysfunction.
• To understand how declining female hormones influence ET-1's vascular effects.

Main Methods:

• Literature review of studies on cardiovascular aging, sex hormones, and the endothelin system.
• Analysis of mechanisms by which female sex steroids interact with ET-1.
• Synthesis of evidence on ET-1's role in postmenopausal vascular pathology.

Main Results:

• The endothelin system, particularly ET-1, is implicated in age-related vascular dysfunction.
• Female sex steroids modulate vascular ET-1 expression and action.
• Loss of hormonal protection post-menopause exacerbates ET-1's detrimental vascular effects.

Conclusions:

• Aging women are at high risk for CVDs like hypertension, myocardial infarction, and stroke.
• ET-1 mediates deleterious effects of aging in postmenopausal females via hormone-dependent pathways.
• Understanding these pathways is crucial for mitigating cardiovascular risk in aging women.